AUTLAutolus Therapeutics plc
2.410USDMkt Cap: 641.45M $P/E: —3d ago
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap641.45M $
Enterprise Value-122.58M $
Revenue (TTM)1.08M $
Gross Profit-20.98M $
Net Income (TTM)-287.53M $
Revenue/Share0.0280 USD
Last Price2.410 USD
Fiscal Year EndDec 2025
MR QuarterDec 2018
Employees752
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS05280R1005
Valuation
P/E (Trailing)—
P/E (Forward)-3.85
PEG—
EV/EBITDA1.78
EV/Revenue-113.65
P/S594.76
P/B0.41
EPS (TTM)-1.06
EPS (Forward)-0.63
52W Range
2.4009% of range2.510
52W High2.510 USD
52W Low2.400 USD
Profitability
Gross Margin-27.83%
Oper. Margin-6570.75%
EBITDA Margin0.00%
Profit Margin-381.40%
ROE-161.42%
ROA-48.81%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-283.57M $
CapEx (TTM)27.13M $
FCF Margin—
FCF Yield—
Net Debt-217.45M $
Net Debt/EBITDA3.15
Balance Sheet
Debt/Equity0.40
Current Ratio11.05
Quick Ratio10.32
Book Value/Sh5.910 USD
Cash/Share5.524 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.725 USD
Upside (mean)+262.0%
Target Range5.000 USD – 11.00 USD
$5.000+262.0% to mean$11.00
# Analysts8
Ownership
Shares Out.266.16M
Float33.90M
Insiders18.08%
Institutions63.42%
Short Interest
Short Ratio12.3d
Short % Float7.99%
Short % Out.5.18%
Shares Short13.79M
Short (prev mo.)12.49M
Technical
SMA 501.728 (+39.5%)
SMA 2001.579 (+52.7%)
Beta—
S&P 52W Chg19.18%
Avg Vol (30d)2.32M
Avg Vol (10d)3.92M
Technical Indicators
RSI (14)66.6
MACD0.2224
MACD Signal0.1815
MACD Hist.+0.0408
BB Upper2.721 USD
BB Middle2.002 USD
BB Lower1.283 USD
BB Width71.84%
ATR (14)0.1722 USD
Vol Ratio (20d)0.69x